Orodispersible tablet, BUL03, Jorveza 1 mg orodispersible tablets
BUL-8/EEA
Phase 3 small_molecule active
Quick answer
Orodispersible tablet, BUL03, Jorveza 1 mg orodispersible tablets for eosinophilic esophagitis is a Phase 3 program (small_molecule) at Dr. Falk Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dr. Falk Pharma GmbH
- Indication
- eosinophilic esophagitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active